Status:

RECRUITING

High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain

Lead Sponsor:

Fan BiFa

Collaborating Sponsors:

Peking University Third Hospital

Xuanwu Hospital, Beijing

Conditions:

Painful Diabetic Peripheral Neuropathy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Application of High-Frequency Spinal Cord Stimulation (HF-SCS) in the Treatment of Painful Diabetic Peripheral Neuropathy (PDPN): A multicenter, randomized controlled study comparing its clinical effi...

Detailed Description

The incidence rate of diabetes peripheral neuropathic pain (DPNP) is high, and there is no clear and effective treatment, which is a clinical problem to be solved urgently. Traditional spinal cord el...

Eligibility Criteria

Inclusion

  • Diagnosed with diabetes, aged between 18 and 80 years old;
  • Symmetrical pain in the distal lower extremities with or without dysesthesia;
  • Duration of symptoms exceeding 6 months;
  • Pain described as stabbing and/or electric shock-like and/or burning sensation;
  • Abnormal Quantitative Sensory Testing (QST);
  • Presence of hyperalgesia and allodynia;
  • Absence of lower limb reflexes and muscle strength abnormalities;
  • Normal MRI or CT scans without spinal canal stenosis or other spinal abnormalities.

Exclusion

  • Concurrent severe cardiovascular and cerebrovascular diseases;
  • History of lumbar spine surgery, trauma, or spinal canal stenosis within the past 6 months, or a history of lumbar spine surgery, trauma, or spinal canal stenosis that would impact the SCS surgery and pain assessment in this study;
  • Presence of radicular symptoms;
  • Other spinal abnormalities, such as benign or malignant tumors, congenital abnormalities of the spine, spinal instability, etc.;
  • Coexisting disorders of the coagulation system, malignant tumors, infections, and psychiatric or psychological disorders;
  • Pregnancy.

Key Trial Info

Start Date :

January 6 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT06158529

Start Date

January 6 2025

End Date

December 31 2025

Last Update

February 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China-Japan Friendship Hospital

Beijing, China